Bactiguard Holding
49,8 SEK -1,58%Vær den første som følger denne virksomhed
Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.
Omsætning
201,55 mio.
EBIT %
-65,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BACTI B
Daglig lav / høj pris
49,8 / 52,8
SEK
Markedsværdi
1,75 mia. SEK
Aktieomsætning
104,51 t SEK
Volumen
2,1 t
Seneste videoer
Finanskalender
Delårsrapport
24.10.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
TomBact AB | 18,4 % | 34,4 % |
GIDL Invest AB | 17,6 % | 34,0 % |
Jan Ståhlberg | 10,3 % | 5,1 % |
Nordea Investment Fund | 10,1 % | 5,0 % |
Fjärde AP-fonden | 9,9 % | 4,9 % |
Handelsbanken fonder | 6,0 % | 3,0 % |
TomEnterprise Public Capital AB | 5,4 % | 2,7 % |
AMF - Försäkring och Fonder | 4,9 % | 2,4 % |
Försäkringsaktiebolaget, Avanza Pension | 3,4 % | 1,7 % |
Lancelot Avalon Master | 1,4 % | 0,7 % |
ViserAlle indholdstyper
Carnegie Commissioned Research: Bactiguard: Better than expected Q2 driven by higher licence revenue
Bactiguard, Audiocast with teleconference, Q2'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools